Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Opus Genetics disclosed the approval of equity awards for ten new non-executive employees under its 2021 Inducement Plan. The grants consist of options to purchase an aggregate of 698,000 shares, vesting over four years with a 25% cliff after one year.
Key figures
- Shares granted
- 698000
- Vesting period years
- 4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.